Cargando…

A study of the regional differences in propacetamol-related adverse events using VigiBase data of the World Health Organization

Upon withdrawal of propacetamol, an injectable formulation of the paracetamol prodrug, in Europe due to safety concerns, South Korea’s regulatory body requested a post-marketing surveillance study exploring its safety profile. We characterized regional disparities in adverse events (AE) associated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Han Eol, Bea, Sungho, Yoon, Dongwon, Jung, Juhong, Park, Seung-Mok, Jeon, Juhee, Ye, Young-Min, Lee, Jae-Hyun, Shin, Ju-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747950/ https://www.ncbi.nlm.nih.gov/pubmed/36513759 http://dx.doi.org/10.1038/s41598-022-26211-0

Ejemplares similares

VigiAccess: Promoting public access to VigiBase
por: Shankar, Pathiyil Ravi
Publicado: (2016)

Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines
por: Dutta, Siddhartha, et al.
Publicado: (2022)

Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBase
por: Zhang, Qingxia, et al.
Publicado: (2022)

Reporting Antimicrobial-Related Adverse Drug Events in Jordan: An Analysis from the VigiBase Database
por: Mhaidat, Nizar Mahmoud, et al.
Publicado: (2023)

The completeness of adverse drug reaction reports in South Africa: An analysis in VigiBase(®)
por: Matlala, Mafora F., et al.
Publicado: (2023)

Global adverse events reported for direct-acting antiviral therapies for the treatment of hepatitis C: an analysis of the World Health Organization VigiBase
por: Hayes, Kaleen N., et al.
Publicado: (2021)

Adverse Event Reporting with Immune Checkpoint Inhibitors in Older Patients: Age Subgroup Disproportionality Analysis in VigiBase
por: Noseda, Roberta, et al.
Publicado: (2021)

Fatal Adverse Events of Dabigatran Combined With Aspirin in Elderly Patients: An Analysis Using Data From VigiBase
por: Zhang, Qingxia, et al.
Publicado: (2021)

Investigating Overlap in Signals from EVDAS, FAERS, and VigiBase(®)
por: Vogel, Ulrich, et al.
Publicado: (2020)

Short communication: Comments on hair disorders associated with dupilumab based on VigiBase
por: Park, Sunny, et al.
Publicado: (2022)

Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase
por: Calapai, Fabrizio, et al.
Publicado: (2023)

Montelukast and Nightmares: Further Characterisation Using Data from VigiBase
por: Watson, Sarah, et al.
Publicado: (2022)

Infections associated with clozapine: a pharmacovigilance study using VigiBase(®)
por: Chrétien, Basile, et al.
Publicado: (2023)

Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports
por: Wakao, Rika, et al.
Publicado: (2019)

Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites
por: Juhlin, Kristina, et al.
Publicado: (2015)

Characterization of VigiBase reports on tinnitus associated with bisoprolol—An exploratory and descriptive study
por: Watson, Sarah, et al.
Publicado: (2021)

Ocular surface disorders associated with the use of dupilumab based on WHO VigiBase
por: Park, Sunny, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors and Pregnancy: Analysis of the VigiBase(®) Spontaneous Reporting System
por: Noseda, Roberta, et al.
Publicado: (2022)

Safety Profiles of mRNA COVID-19 Vaccines Using World Health Organization Global Scale Database (VigiBase): A Latent Class Analysis
por: Lee, Min-Taek, et al.
Publicado: (2022)

Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase
por: Fernandez, Silvia, et al.
Publicado: (2021)

Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase(®)
por: Sessa, Maurizio, et al.
Publicado: (2019)

Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020
por: Rocca, Elena, et al.
Publicado: (2021)

A VigiBase Descriptive Study of Fluoroquinolone-Associated Peripheral Nervous System Disorders
por: Huruba, Madalina, et al.
Publicado: (2022)

Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase
por: Willemen, Marjolein J., et al.
Publicado: (2011)

Intravitreal Anti-VEGF Drugs and Signals of Dementia and Parkinson-Like Events: Analysis of the VigiBase Database of Spontaneous Reports
por: Sultana, Janet, et al.
Publicado: (2020)

Adverse Drug Reaction Onsets in Uganda’s VigiBase(®): Delayed International Visibility, Data Quality and Illustrative Signal Detection Analyses
por: Kiguba, Ronald, et al.
Publicado: (2018)

Valproic Acid and Fatalities in Children: A Review of Individual Case Safety Reports in VigiBase
por: Star, Kristina, et al.
Publicado: (2014)

Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase(®)
por: Chandler, Rebecca E., et al.
Publicado: (2016)

Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre
por: Star, Kristina, et al.
Publicado: (2019)

Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study
por: Garcia, Philippe, et al.
Publicado: (2020)

Reporting of Acute Inflammatory Neuropathies with COVID-19 Vaccines: Subgroup Disproportionality Analyses in VigiBase
por: Noseda, Roberta, et al.
Publicado: (2021)

Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database
por: Pochet, Stéphanie, et al.
Publicado: (2022)

Indapamide-Induced Rhabdomyolysis: An Evaluation of Case Reports in VigiBase Using the Bradford Hill Criteria
por: Yue, Qun-Ying, et al.
Publicado: (2022)

Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase
por: Gatti, Milo, et al.
Publicado: (2021)

Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase
por: Sandberg, Lovisa, et al.
Publicado: (2020)

Gastrointestinal toxicities associated with immune checkpoint inhibitors: a disproportionality analysis leveraging VigiBase, the WHO Adverse Drug Reaction Database
por: HUANG, Sifu, et al.
Publicado: (2021)

Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase(®)
por: Ampadu, Haggar H., et al.
Publicado: (2016)

Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study
por: Minnema, Lotte A., et al.
Publicado: (2019)

Drug interactions with apixaban: A systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports
por: Fernandez, Silvia, et al.
Publicado: (2020)

Mapping endocrine toxicity spectrum of immune checkpoint inhibitors: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase
por: Bai, Xuefeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_83bmplk96isl2o6r5p1p34uft2